Literature DB >> 12716921

Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors.

Silvia Marinelli1, Vincenzo Di Marzo, Nicola Berretta, Isabel Matias, Mauro Maccarrone, Giorgio Bernardi, Nicola B Mercuri.   

Abstract

Growing evidence regarding the function of vanilloid receptor-1 (VR1) in the brain suggests potential central roles of this receptor, previously described to occur primarily in peripheral sensory neurons. In the present study, we used electrophysiological and biochemical techniques to investigate the function and the endogenous stimulation of VR1 in dopaminergic neurons of the substantia nigra pars compacta (SNc). The VR1 agonist capsaicin increased the frequency of both TTX-sensitive and -insensitive spontaneous EPSCs (sEPSCs) without affecting their amplitude, suggesting a presynaptic site of action. In contrast, no effect was detected with regard to GABAergic transmission. No increase in sEPSC frequency was observed in the presence of cadmium chloride, while the voltage-dependent calcium channel antagonist omega-conotoxin MVIIC did not prevent capsaicin action. The VR1 antagonists capsazepine and iodoresiniferatoxin (IRTX) blocked the effects of capsaicin. Importantly, IRTX per se reduced sEPSC frequency, suggesting a tonic activity of VR1. The endogenous VR1 agonist anandamide (AEA) produced an IRTX-sensitive increase in the frequency of sEPSCs on dopaminergic neurons that was more pronounced when protein kinase A had been activated. Furthermore, mass spectrometric analyses and binding experiments revealed high levels of endogenous AEA and specific binding of AEA to VR1 receptors in the SNc. These data suggest a tonic facilitation of glutamate release exerted by VR1 in the SNc through a stimulation of VR1 by endovanilloids, including anandamide. The increase in sEPSC frequency by VR1 onto midbrain dopaminergic neurons suggests the involvement of these receptors in motor and cognitive functions involving the dopaminergic system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716921      PMCID: PMC6742307     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  49 in total

Review 1.  New perspectives on enigmatic vanilloid receptors.

Authors:  A Szallasi; V Di Marzo
Journal:  Trends Neurosci       Date:  2000-10       Impact factor: 13.837

2.  Molecular cloning of an N-terminal splice variant of the capsaicin receptor. Loss of N-terminal domain suggests functional divergence among capsaicin receptor subtypes.

Authors:  M A Schumacher; I Moff; S P Sudanagunta; J D Levine
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

3.  Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease.

Authors:  V Di Marzo; M P Hill; T Bisogno; A R Crossman; J M Brotchie
Journal:  FASEB J       Date:  2000-07       Impact factor: 5.191

Review 4.  Capsaicin, protons and heat: new excitement about nociceptors.

Authors:  M Kress; H U Zeilhofer
Journal:  Trends Pharmacol Sci       Date:  1999-03       Impact factor: 14.819

5.  Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.

Authors:  D Melck; T Bisogno; L De Petrocellis; H Chuang; D Julius; M Bifulco; V Di Marzo
Journal:  Biochem Biophys Res Commun       Date:  1999-08-19       Impact factor: 3.575

6.  Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.

Authors:  P M Zygmunt; J Petersson; D A Andersson; H Chuang; M Sørgård; V Di Marzo; D Julius; E D Högestätt
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

7.  Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors.

Authors:  M Maccarrone; T Lorenzon; M Bari; G Melino; A Finazzi-Agro
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

8.  Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.

Authors:  T Bisogno; F Berrendero; G Ambrosino; M Cebeira; J A Ramos; J J Fernandez-Ruiz; V Di Marzo
Journal:  Biochem Biophys Res Commun       Date:  1999-03-16       Impact factor: 3.575

9.  The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).

Authors:  D Smart; M J Gunthorpe; J C Jerman; S Nasir; J Gray; A I Muir; J K Chambers; A D Randall; J B Davis
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

10.  Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human.

Authors:  E Mezey; Z E Tóth; D N Cortright; M K Arzubi; J E Krause; R Elde; A Guo; P M Blumberg; A Szallasi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  75 in total

1.  Short-term increases in transient receptor potential vanilloid-1 mediate stress-induced enhancement of neuronal excitation.

Authors:  Carl Weitlauf; Nicholas J Ward; Wendi S Lambert; Tatiana N Sidorova; Karen W Ho; Rebecca M Sappington; David J Calkins
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

Review 2.  Emerging roles for endocannabinoids in long-term synaptic plasticity.

Authors:  Gregory L Gerdeman; David M Lovinger
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

3.  TRPV1: a stress response protein in the central nervous system.

Authors:  Karen W Ho; Nicholas J Ward; David J Calkins
Journal:  Am J Neurodegener Dis       Date:  2012-04-01

4.  TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons.

Authors:  Helen E Gibson; Jeffrey G Edwards; Rachel S Page; Matthew J Van Hook; Julie A Kauer
Journal:  Neuron       Date:  2008-03-13       Impact factor: 17.173

Review 5.  Endocannabinoids in the dentate gyrus.

Authors:  Charles J Frazier
Journal:  Prog Brain Res       Date:  2007       Impact factor: 2.453

Review 6.  Anandamide and vanilloid TRPV1 receptors.

Authors:  Ruth A Ross
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

7.  Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels.

Authors:  Mario van der Stelt; Marcello Trevisani; Vittorio Vellani; Luciano De Petrocellis; Aniello Schiano Moriello; Barbara Campi; Peter McNaughton; Piero Geppetti; Vincenzo Di Marzo
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

8.  Loss of interneuron LTD and attenuated pyramidal cell LTP in Trpv1 and Trpv3 KO mice.

Authors:  Travis E Brown; Anda M Chirila; Benjamin R Schrank; Julie A Kauer
Journal:  Hippocampus       Date:  2013-06-03       Impact factor: 3.899

9.  Absence of transient receptor potential vanilloid-1 accelerates stress-induced axonopathy in the optic projection.

Authors:  Nicholas J Ward; Karen W Ho; Wendi S Lambert; Carl Weitlauf; David J Calkins
Journal:  J Neurosci       Date:  2014-02-26       Impact factor: 6.167

10.  TRPV1: a target for next generation analgesics.

Authors:  Louis S Premkumar; Parul Sikand
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.